Adverse Cardiac Events of Hypercholesterolemia Are Enhanced by Sitagliptin in Sprague Dawley Rats

Overview

Journal Nutr Metab (Lond)

Publisher Biomed Central

Date 2024 Jul 31

PMID 39080769

Authors

Henry A Palfrey

Avinash Kumar

Rashmi Pathak

Kirsten P Stone

Thomas W Gettys

Subramanyam N Murthy

Affiliations

Soon will be listed here.

Abstract

Background: Cardiovascular disease (CVD) affects millions worldwide and is the leading cause of death among non-communicable diseases. Western diets typically comprise of meat and dairy products, both of which are rich in cholesterol (Cho) and methionine (Met), two well-known compounds with atherogenic capabilities. Despite their individual effects, literature on a dietary combination of the two in the context of CVD are limited. Therefore, studies on the combined effects of Cho and Met were carried out using male Sprague Dawley rats. An additional interest was to investigate the cardioprotective potential of sitagliptin, an anti-type 2 diabetic drug. We hypothesized that feeding a dietary combination of Cho and Met would result in adverse cardiac effects and would be attenuated upon administration of sitagliptin.

Methods: Adult male Sprague-Dawley rats were fed either a control (Con), high Met (1.5%), high Cho (2.0%), or high Met (1.5%) + high Cho (2.0%) diet for 35 days. They were orally gavaged with an aqueous preparation of sitagliptin (100 mg/kg/d) or vehicle (water) from day 10 through 35. On day 36, rats were euthanized, and tissues were collected for analysis.

Results: Histopathological evaluation revealed a reduction in myocardial striations and increased collagen deposition in hypercholesterolemia (HChol), responses that became exacerbated upon sitagliptin administration. Cardiac pro-inflammatory and pro-fibrotic responses were adversely impacted in similar fashion. The addition of Met to Cho (MC) attenuated all adverse structural and biochemical responses, with or without sitagliptin.

Conclusions: Adverse cardiac outcomes in HChol were enhanced by the administration of sitagliptin, and such effects were alleviated by Met. Our findings could be significant for understanding or revisiting the risk-benefit evaluation of sitagliptin in type 2 diabetics, and especially those who are known to consume atherogenic diets.

References

Kawai T, Autieri M, Scalia R . Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2020; 320(3):C375-C391. PMC: 8294624. DOI: 10.1152/ajpcell.00379.2020. View

Packer M . Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications. JACC Heart Fail. 2018; 6(6):445-451. DOI: 10.1016/j.jchf.2017.12.016. View

Kaur D, Tallman D, Khosla P . The health effects of saturated fats - the role of whole foods and dietary patterns. Diabetes Metab Syndr. 2020; 14(2):151-153. DOI: 10.1016/j.dsx.2020.02.002. View

Carson J, Lichtenstein A, Anderson C, Appel L, Kris-Etherton P, Meyer K . Dietary Cholesterol and Cardiovascular Risk: A Science Advisory From the American Heart Association. Circulation. 2019; 141(3):e39-e53. DOI: 10.1161/CIR.0000000000000743. View

Cerqueira N, Oliveira E, Gesto D, Santos-Martins D, Moreira C, Moorthy H . Cholesterol Biosynthesis: A Mechanistic Overview. Biochemistry. 2016; 55(39):5483-5506. DOI: 10.1021/acs.biochem.6b00342. View

Spence J . Dietary cholesterol and egg yolk should be avoided by patients at risk of vascular disease. J Transl Int Med. 2017; 4(1):20-24. PMC: 5290910. DOI: 10.1515/jtim-2016-0005. View

Pan J, Zhang H, Lin H, Gao L, Zhang H, Zhang J . Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells. Redox Biol. 2021; 46:102120. PMC: 8413906. DOI: 10.1016/j.redox.2021.102120. View

Tsao C, Vasan R . Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology. Int J Epidemiol. 2015; 44(6):1800-13. PMC: 5156338. DOI: 10.1093/ije/dyv337. View

Luo J, Yang H, Song B . Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2019; 21(4):225-245. DOI: 10.1038/s41580-019-0190-7. View

10.

Pathak R, Kumar A, Palfrey H, Forney L, Stone K, Raju N . The incretin enhancer, sitagliptin, exacerbates expression of hepatic inflammatory markers in rats fed a high-cholesterol diet. Inflamm Res. 2019; 68(7):581-595. PMC: 6602907. DOI: 10.1007/s00011-019-01243-x. View

11.

Han Q, Yeung S, Ip M, Mak J . Dysregulation of cardiac lipid parameters in high-fat high-cholesterol diet-induced rat model. Lipids Health Dis. 2018; 17(1):255. PMC: 6237003. DOI: 10.1186/s12944-018-0905-3. View

12.

Hermann A, Sitdikova G . Homocysteine: Biochemistry, Molecular Biology and Role in Disease. Biomolecules. 2021; 11(5). PMC: 8156138. DOI: 10.3390/biom11050737. View

13.

Frostegard J . Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013; 11:117. PMC: 3658954. DOI: 10.1186/1741-7015-11-117. View

14.

Frangogiannis N . The Extracellular Matrix in Ischemic and Nonischemic Heart Failure. Circ Res. 2019; 125(1):117-146. PMC: 6588179. DOI: 10.1161/CIRCRESAHA.119.311148. View

15.

Hasan I, Rainsford K, Ross J . Salsalate: a pleotropic anti-inflammatory drug in the treatment of diabetes, obesity, and metabolic diseases. Inflammopharmacology. 2023; 31(6):2781-2797. DOI: 10.1007/s10787-023-01242-9. View

16.

Venugopal H, Hanna A, Humeres C, Frangogiannis N . Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction. Cells. 2022; 11(9). PMC: 9102016. DOI: 10.3390/cells11091386. View

17.

McCully K . Hyperhomocysteinemia and arteriosclerosis: historical perspectives. Clin Chem Lab Med. 2005; 43(10):980-6. DOI: 10.1515/CCLM.2005.172. View

18.

Clemente-Suarez V, Mielgo-Ayuso J, Martin-Rodriguez A, Ramos-Campo D, Redondo-Florez L, Tornero-Aguilera J . The Burden of Carbohydrates in Health and Disease. Nutrients. 2022; 14(18). PMC: 9505863. DOI: 10.3390/nu14183809. View

19.

Ramezani Kapourchali F, Surendiran G, Goulet A, Moghadasian M . The Role of Dietary Cholesterol in Lipoprotein Metabolism and Related Metabolic Abnormalities: A Mini-review. Crit Rev Food Sci Nutr. 2015; 56(14):2408-15. DOI: 10.1080/10408398.2013.842887. View

20.

Shirazi L, Bissett J, Romeo F, Mehta J . Role of Inflammation in Heart Failure. Curr Atheroscler Rep. 2017; 19(6):27. DOI: 10.1007/s11883-017-0660-3. View